Apposite Capital, the private equity firm with an exclusive focus on healthcare, has raised £144.5m (€164m) for its Apposite Healthcare Fund II and associated vehicles.
The fund has received support from funds, financial institutions, family offices, endowments, foundations and corporates from Europe, Asia and the US. It will invest between £10m and £20m in healthcare companies in the UK and Europe.
The fund has already made five investments, backing Medical Imaging Partnership, MC Care Holdings, NIMGenetics, Swanton Care & Community and OrthoD Group. TMR Strategic served as placement agent with Macfarlanes acting as legal adviser.
“It reflects the quality of our team and track record as well as investors’ growing appetite for specialist sector focused managers,” Apposite managing partner David Porter said of the fundraise. “We look forward to further deploying the fund and to providing growth and small buyout capital to healthcare businesses in the UK and Europe with high growth potential.”
Apposite has also announced the promotions of Valerie Auffray and Anne-Laure Meynier to head of investor relations and operations, and investment director respectively.
Auffray joined Apposite Capital in 2008. She is responsible for fundraising, investor relations, funds reporting, marketing, as well as the firm’s operations.
Meynier joined the firm in 2015 and is involved in all aspects of the investment process from originating to executing and managing investments. She serves as a director of NIMGenetics and is an observer on the Swanton Care & Community board.